MSK Biomarker Ctte

From QIBA Wiki

Revision as of 15:44, 27 September 2022 by SStanfa (talk | contribs) (→Meetings)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Co-chairs: Xiaojuan Li, PhD; Thomas M. Link, MD, PhD
RSNA Staff Support: Susan Stanfa

Roster

The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.

Meetings

Approved call summaries:

MSK Biomarker Committee Call Summaries Archive

Profile Documents

MR-based cartilage compositional biomarkers (T1ρ, T2) for risk prediction, early diagnosis and monitoring of treatment of degenerative joint disease 2021-09-25 - Consensus Profile
MR-based cartilage compositional biomarkers (T1ρ, T2) for risk prediction, early diagnosis and monitoring of treatment of degenerative joint disease 2020-01-28 - Public Comment Profile

Statistical Reference Documents

Workflow Documents

Reference Materials

Retrieved from "https://qibawiki.rsna.org/index.php?title=MSK_Biomarker_Ctte&oldid=18548"